Patent US5028703A successfully refreshed from Google Patents.
← Back to Patent Explorer
US5028703A Expired / Lapsed US ⏱️ 0.0 years remaining

Glucan composition and process for preparation thereof

Assignee: Massachusetts Institute of Technology
•
Filing: 1989-04-05
•
Granted: 1991-07-02
•
Expires: 2009-04-05
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Three dimensional glucan matrix compositions are prepared by separating growing yeast from its growth medium, subjecting the yeast with cell walls intact to an alkali material, thereby extracting whole glucan particles having an intact cell wall structure. The whole glucans can then, optionally, be treated with acetic acid to alter the β(1-6) linkages, or with glucanase to alter the β(1-3) linkages. The glucans have viscosity characteristics dependent upon the strain of yeast utilized and are useful as stabilizers or thickeners.

Inventors

  • 👤 Spiros Jamas
  • 👤 ChoKyun Rha
  • 👤 Anthony J. Sinskey

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-24 19:44
CPC Classifications
C; C12; C12P; C12P19/00; C12P19/04; C08; C08B; C08B37/00; C08B37/0006; C08B37/0024

Claims Analysis

Total Claims: 17
Claim 1
Independent Claim 60 words
Whole glucan particles substantially retaining the in vivo glucan morphology and isolated from glucan-containing cell walls of genetically modified cells, the β(1-6) linkages in said whole glucans being altered sufficiently to provide a significant difference in the resistance to hydrolysis by β(1-3) glucanases compared to the resistance to hydrolysis by β(1-3) glucanases of whole glucans from comparable non-genetically modified cells.
Claim 2
Dependent Claim 60 words
Whole glucan particles substantially retaining the in vivo glucan morphology and isolated from glucan-containing cell walls of genetically modified cells, the β(1-6) linkages in said whole glucans being altered sufficiently to provide a significant difference in the resistance to hydrolysis by β(1-3) glucanases compared to the resistance to hydrolysis by β(1-3) glucanases of whole glucans from comparable non-genetically modified cells.
Claim 3
Dependent Claim 16 words
Altered whole glucan particles of claim 1 which are isolated from a mutated strain of yeast.
Claim 4
Dependent Claim 77 words
Altered whole glucan particles of claim 2 wherein the mutated yeast strain is a mutant strain of Saccharomyces cerevisiae, Saccharomyces delbrueckii, Saccharomyces rosei, Saccaromyces microellipsodes, Saccharomyces carlsbergensis, Saccharomyces bisporus, Saccharomyces fermentati, Saccharomyces rouxii, Schizosaccharomyces pombe, Kluyveromyces lactis, Kluyveromyces fragilis, Kluyveromyces polysporus, Candida albicans, Candida cloacae, Candidatropicalis, Candida utilis, Hansenula wingei, Hansenula arni, Hansenula henricii, Hansenula americana, Hansenula canadiensis, Hansenula capsulata, Hansenula polymorpha, Pichia kluyveri, Pichia pastoris, Pichia polymorpha, Pichia rhodanensis, Pichia ohmeri, Torulopsis bovina and Torulopsis glabrata.
Claim 5
Dependent Claim 17 words
Altered whole glucan particles of claim 3 which are isolated from a mutant strain of Saccharomyces cerevisiae.
Claim 6
Dependent Claim 18 words
Altered whole glucan particles of claim 4 wherein the mutant strain of Saccharomyces cerevisiae comprises Saccharomyces cerevisiae R4.
Claim 7
Dependent Claim 15 words
Altered whole glucan particles of claim 5 containing less than one percent, by weight, protein.
Claim 8
Dependent Claim 15 words
Altered whole glucan particles of claim 1 containing less than one percent, by weight, protein.
Claim 9
Dependent Claim 19 words
Altered whole glucan particles of claim 7 having a particle size of from about 2 to about 10 microns.
Claim 10
Dependent Claim 26 words
Altered whole glucan particles of claim 1 wherein the genetically modified cells comprise glucan-containing cells having DNA which has been genetically modified by in vitro techniques.
Claim 11
Dependent Claim 14 words
Altered whole glucan particles of claim 9 wherein said glucan-containing cells comprise yeast cells.
Claim 12
Dependent Claim 98 words
A process for preparing altered whole glucan particles comprising the steps of: (a) exposing glucan-containing cells to a mutagen under conditions sufficient to produce mutant cells which produce glucans containing β(1-6) linkages sufficiently altered to provide a significant difference in the resistance to hydrolysis by β(1-3) glucanases compared to whole glucans isolated from the non-mutated cells; and (b) isolating altered whole glucan particles from the cell walls of said mutant cells without a prior step of disrupt the cell walls and under conditions sufficient for said isolated whole glucan particles to substantially retain the in vivo glucan morphology.
Claim 13
Dependent Claim 98 words
A process for preparing altered whole glucan particles comprising the steps of: (a) exposing glucan-containing cells to a mutagen under conditions sufficient to produce mutant cells which produce glucans containing β(1-6) linkages sufficiently altered to provide a significant difference in the resistance to hydrolysis by β(1-3) glucanases compared to whole glucans isolated from the non-mutated cells; and (b) isolating altered whole glucan particles from the cell walls of said mutant cells without a prior step of disrupt the cell walls and under conditions sufficient for said isolated whole glucan particles to substantially retain the in vivo glucan morphology.
Claim 14
Dependent Claim 12 words
A process of claim 11 wherein the glucan-containing cells are yeast cells.
Claim 15
Dependent Claim 16 words
A process of claim 12 wherein the yeast cells comprise a strain of mutated Saccharomyces cerevisiae.
Claim 16
Dependent Claim 16 words
A process of claim 13 wherein the mutated strain of Saccharomyces cerevisiae comprises Saccharomyces cerevisiae A364A.
Claim 17
Dependent Claim 24 words
A process of claim 14 wherein step (a) is performed by exposing a cell culture of Saccharomyces cerevisiae A364A yeast cells to ultraviolet radiation.

References Cited (Backward Citations)

US4075405A Cited
US4707471A Cited
US4769363A Cited
US4810646A Cited
US4806474A Cited
US4835265A Cited
US4877777A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1994-07-01 1994-12-31 1995-07-02 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1998-07-01 1998-12-31 1999-07-02 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2002-07-01 2002-12-31 2003-07-02 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag